COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,356 | +125.2% | 630,000 | +157.1% | 0.90% | +116.1% |
Q2 2023 | $1,046 | +2.8% | 245,010 | +90.6% | 0.42% | +8.1% |
Q4 2022 | $1,018 | -99.9% | 128,517 | -35.7% | 0.38% | -52.4% |
Q3 2022 | $1,922,000 | +42.6% | 200,000 | +7.4% | 0.81% | +42.9% |
Q2 2022 | $1,348,000 | -11.2% | 186,134 | +58.3% | 0.57% | +17.2% |
Q1 2022 | $1,518,000 | -7.3% | 117,555 | +14.6% | 0.48% | -13.1% |
Q4 2021 | $1,637,000 | – | 102,555 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |